• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Assessing NOVONIX’s Valuation After Share Price Gains And Ongoing Push Toward Profitability

    Simply Wall St·01/08/2026 09:33:32
    語音播報

    What is drawing attention to NOVONIX right now?

    Recent interest in NOVONIX (ASX:NVX) is tied to share price gains that investors are linking to its ongoing revenue growth and execution of long term plans, while the company continues working toward profitability.

    See our latest analysis for NOVONIX.

    The recent enthusiasm follows a sharp 22.6% 7-day share price return and a 21.2% 30-day share price return to A$0.515. However, the 1-year total shareholder return remains a 29.5% loss and the 3-year total shareholder return is a 71.2% loss, so current momentum is emerging off a much weaker long-run base.

    If NOVONIX has caught your eye, it can also be useful to scan other battery-related and electrification names through high growth tech and AI stocks and see how they compare on growth, risks and valuation.

    With revenue of about A$5.93m, a reported loss of A$66.25m and a share price still well below where it was a few years ago, is NOVONIX looking mispriced, or does the recent rebound already reflect future growth expectations?

    Price-to-Sales of 49x: Is it justified?

    At A$0.515, NOVONIX is trading on a P/S of 49x, which immediately stands out when you compare it to both peers and the wider electronic industry.

    The P/S ratio compares the company’s market value to its revenue, so for NOVONIX investors are effectively paying 49 times its current annual sales. For a business that is still loss making, investors often look at this multiple to judge how much future revenue growth is already being factored into the price.

    In this context, NOVONIX is described as good value relative to an estimated fair P/S of 110.1x. This is a level the market could potentially move toward if current expectations are maintained. At the same time, the 49x multiple is described as expensive compared with the global electronic industry average of 1.8x and a peer average of 25.1x. This suggests that the market is assigning NOVONIX a much richer revenue multiple than many comparable names.

    Explore the SWS fair ratio for NOVONIX

    Result: Price-to-Sales of 49x (OVERVALUED)

    However, the loss of A$66.25m on revenue of A$5.93m and a 71.2% 3 year total shareholder loss could challenge confidence in the current P/S premium.

    Find out about the key risks to this NOVONIX narrative.

    Build Your Own NOVONIX Narrative

    If you see the numbers differently or prefer to work through the data yourself, you can build a custom view of NOVONIX in just a few minutes with Do it your way.

    A great starting point for your NOVONIX research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.

    Looking for more investment ideas?

    If NOVONIX is only one piece of your watchlist, it makes sense to widen the net now and see what other opportunities might be hiding in plain sight.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.